Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 57222153956

Countries

United States, Saudi Arabia

Activities

Collapse all

Employment (1)

Qassim University: Buraidah, SA

2024-05-19 to present | Assistant Professor (Pharmacy Practice)
Employment
Source: Self-asserted source
Abdulrahman Alsuhibani

Works (16)

Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model

ClinicoEconomics and Outcomes Research
2025-03 | Journal article
DOI: 10.2147/CEOR.S503842
Contributors: Ziyad Almalki; Mashael Alshammari; Saja Almazrou; Ohud Alqahtani; Maryam Alkhayat; Shahad Alnemari; Haya Mukhemair; Sara Alkredeas; Abdulrahman Alsuhibani; Bushra Asiri et al.
Source: check_circle
Crossref

Factors Associated with Statin Discontinuation Following Metabolic and Bariatric Surgery: A Retrospective Analysis of 2012–2021 Electronic Medical Records Network Data

Obesity Surgery
2024 | Journal article
DOI: 10.1007/s11695-024-07110-x
EID:

2-s2.0-85185949525

Part of ISSN: 17080428 09608923
Contributors: Alsuhibani, A.A.; Al-Obeed, O.A.; Wigle, P.R.; Alsultan, M.M.; Guo, J.J.; Lin, A.C.; Rao, M.B.; Hincapie, A.L.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier
grade
Preferred source (of 2)‎

Pharmacy students’ interprofessional experience and performance in advanced pharmacy practice experience rotations amid COVID-19 pandemic

Frontiers in Medicine
2024 | Journal article
DOI: 10.3389/fmed.2024.1394652
EID:

2-s2.0-85195060132

Part of ISSN: 2296858X
Contributors: Alrasheed, M.; Alsuhibani, A.; Alotaibi, W.; Gari, M.; Alashgar, A.; Doherty, M.; Boone, J.; Almangour, T.A.; Hincapie, A.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier

A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries

Surgery
2024-09 | Journal article
DOI: 10.1016/j.surg.2024.05.024
Contributors: Abdulrahman A. Alsuhibani; Azzam Al-Kadi; Patricia R. Wigle; Jeff Jianfei Guo; Alex C. Lin; Marepalli B. Rao; Ana L. Hincapie
Source: check_circle
Crossref

Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022

Pharmaceuticals
2024-06-21 | Journal article
DOI: 10.3390/ph17070815
Contributors: Marwan A. Alrasheed; Khalid A. Alamer; Mashael Albishi; Abdulrahman A. Alsuhibani; Omar A. Almohammed; Abdulrahman Alwhaibi; Abdullah N. Almajed; Jeff J. Guo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Drug Expenditure, Price, and Utilization in US Medicaid_ A Trend Analysis for New Multiple Myeloma Medications from 2016 to 2022

Healthcare (Switzerland)
2023 | Journal article
DOI: 10.3390/healthcare11162265
EID:

2-s2.0-85169092220

Part of ISSN: 22279032
Contributors: Alrasheed, M.; Alsuhibani, A.; Balkhi, B.; Guo, J.J.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier
grade
Preferred source (of 3)‎

Utilization, reimbursement, and price trends for Hepatitis C virus medications in the US Medicaid programs: 2001–2021

Exploratory Research in Clinical and Social Pharmacy
2023 | Journal article
DOI: 10.1016/j.rcsop.2023.100383
EID:

2-s2.0-85179058090

Part of ISSN: 26672766
Contributors: Gari, M.H.; Alsuhibani, A.; Alashgar, A.; Guo, J.J.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier

Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020

International Journal of Clinical Pharmacy
2022-02 | Journal article
DOI: 10.1007/s11096-021-01330-2
Contributors: Abdulrahman Alsuhibani; Marwan Alrasheed; Musaab Gari; Ana L. Hincapie; Jeff Jianfei Guo
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Changes in utilization of immediate-release, extended-release, and liquid formulation medications relative to bariatric surgery: a segmented regression analysis

Surgery for Obesity and Related Diseases
2021 | Journal article
DOI: 10.1016/j.soard.2021.02.027
EID:

2-s2.0-85103324192

Part of ISSN: 18787533 15507289
Contributors: Vouri, S.M.; Bhagwandass, H.; Valdes, I.L.; Al-Bahou, J.; Alsuhibani, A.; Friedman, J.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier
grade
Preferred source (of 2)‎

Comparison of quality of life between men and women with chronic liver diseases using chronic liver disease questionnaire (CLDQ): A meta-analysis

Pharmacoepidemiology and Drug Safety
2021 | Journal article
WOSUID: WOS:000687807300364
Contributors: Alrasheed, Marwan; Alsuhibani, Abdulrahman; Hincapie, Ana L.; Welge, Jeffrey
Source: check_circle
Web of Science Researcher Profile Sync

Descriptive Analysis of Reported Adverse Events Associated with Antiobesity Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2020

Research Square
2021 | Other
DOI: 10.21203/rs.3.rs-628129/v1
EID:

2-s2.0-85168164842
Contributors: Alsuhibani, A.; Alrasheed, M.; Gari, M.; Hincapie, A.; Guo, J.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier

Descriptive Analysis of Reported Adverse Events Associated with Antiobesity Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013-2020

ResearchSquare
2021 | Other
DOI: 10.21203/rs.3.rs-628129
EID:

2-s2.0-85133362187
Contributors: Alsuhibani, A.; Alrasheed, M.; Gari, M.; Hincapie, A.; Guo, J.
Source: Self-asserted source
Abdulrahman Alsuhibani via Scopus - Elsevier

Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: A retrospective cohort study

Pharmacoepidemiology and Drug Safety
2021 | Journal article
WOSUID: WOS:000687807300843
Contributors: Alsuhibani, Abdulrahman; Albogami, Yasser; Diaby, Vakaramoko; Friedman, Jeffrey; Vouri, Scott Martin
Source: check_circle
Web of Science Researcher Profile Sync

Safety evaluation of panobinostat, ixazomib, elotuzumab, and daratumumab using FDA adverse event reporting system (FAERS) database 2015-2020

Pharmacoepidemiology and Drug Safety
2021 | Journal article
WOSUID: WOS:000687807300678
Contributors: Alrasheed, Marwan; Alsuhibani, Abdulrahman; Hincapie, Ana L.; Guo, Jianfei
Source: check_circle
Web of Science Researcher Profile Sync

Changes in Utilization of Immediate-Release, Extended-Release, and Liquid Formulation Medications relative to Bariatric Surgery: a Segmented Regression Analysis

2021-03-03 | Journal article
Source: Self-asserted source
Abdulrahman Alsuhibani

Evaluation of Statin Discontinuation Stratified by Primary versus Secondary Prevention Following Bariatric Surgery: A Retrospective Cohort Study

Surgery for Obesity and Related Diseases
2021-01 | Journal article
DOI: 10.1016/j.soard.2021.01.025
Contributors: Abdulrahman Alsuhibani; Yasser Albogami; Vakaramoko Diaby; Jeffrey Friedman; Scott Martin Vouri
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Peer review (1 review for 1 publication/grant)

Review activity for Clinical therapeutics. (1)
How many people are using ORCID?